Lifevantage Corporation (LFVN) To Go Ex-Dividend on March 2nd

Lifevantage Corporation (NASDAQ:LFVN) declared a quarterly dividend on Thursday, January 29th. Stockholders of record on Monday, March 2nd will be paid a dividend of 0.045 per share on Monday, March 16th. This represents a c) dividend on an annualized basis and a dividend yield of 3.9%. The ex-dividend date is Monday, March 2nd.

Lifevantage has a dividend payout ratio of 16.7% indicating that its dividend is sufficiently covered by earnings.

Lifevantage Stock Performance

LFVN stock opened at $4.65 on Friday. The stock’s 50 day moving average price is $5.64 and its 200 day moving average price is $8.01. The firm has a market cap of $59.47 million, a P/E ratio of 7.75 and a beta of 0.33. Lifevantage has a 1 year low of $3.90 and a 1 year high of $17.64.

Lifevantage (NASDAQ:LFVN) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.07). Lifevantage had a return on equity of 29.59% and a net margin of 3.74%.The company had revenue of $48.93 million during the quarter, compared to analyst estimates of $54.40 million. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.